The government negotiated quarterly not weekly delivery quotas. France, the United States and the U.K. health authorities have issued concerns with extending the dosing windows due to potential efficacy delays.
Has the government prepared guidelines for the provinces on how best to administer doses, given potentially quarterly supply disruptions?